000

GENEBIOTECH

No trades
See on Supercharts
Market capitalization
‪33.71 B‬KRW
‪2.59 B‬KRW
‪79.48 B‬KRW
‪8.61 M‬
Beta (1Y)
0.17

About GENEBIOTECH

CEO
Chan-Ho Lee
Headquarters
Gongju
Employees (FY)
41
Founded
2000
ISIN
KR7086060001
FIGI
BBG000BHX9W8
Gene Bio Tech Co., Ltd. engages in the manufacture of fermented biomass. It operates through the following divisions: Green Resource, Bio and Technology Resource divisions. The company was founded on March 15, 2000 and is headquartered in Gongju, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 086060 is 3940 KRW — it has increased by 0.64% in the past 24 hours. Watch GENEBIOTECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENEBIOTECH stocks are traded under the ticker 086060.
086060 stock is 1.03% volatile and has beta coefficient of 0.17. Track GENEBIOTECH stock price on the chart and check out the list of the most volatile stocks — is GENEBIOTECH there?
Yes, you can track GENEBIOTECH financials in yearly and quarterly reports right on TradingView.
086060 stock has risen by 1.81% compared to the previous week, the month change is a 1.99% fall, over the last year GENEBIOTECH has showed a 8.80% decrease.
086060 net income for the last quarter is ‪407.47 M‬ KRW, while the quarter before that showed ‪777.87 M‬ KRW of net income which accounts for −47.62% change. Track more GENEBIOTECH financial stats to get the full picture.
Today GENEBIOTECH has the market capitalization of ‪33.71 B‬, it has increased by 0.90% over the last week.
GENEBIOTECH dividend yield was 0% in 2023, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 086060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEBIOTECH stock right from TradingView charts — choose your broker and connect to your account.
As of May 8, 2024, the company has 41.00 employees. See our rating of the largest employees — is GENEBIOTECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEBIOTECH technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEBIOTECH stock shows the sell signal. See more of GENEBIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEBIOTECH EBITDA is ‪4.98 B‬ KRW, and current EBITDA margin is 6.27%. See more stats in GENEBIOTECH financial statements.